Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6
Upon target RNA recognition, type III CRISPR-Cas systems produce cyclic oligoadenylates that activate effectors such as Csm6 ribonucleases. Here, Garcia-Doval et al. show that Enteroccocus italicus Csm6 degrades its cyclic hexa-AMP activator, and report the crystal structure of the protein bound to...
Guardado en:
Autores principales: | Carmela Garcia-Doval, Frank Schwede, Christian Berk, Jakob T. Rostøl, Ole Niewoehner, Oliver Tejero, Jonathan Hall, Luciano A. Marraffini, Martin Jinek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72db17b42bde4a3aab3bcb1de11e229a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate
por: Stephen A. McMahon, et al.
Publicado: (2020) -
CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens.
por: Luciano A Marraffini
Publicado: (2013) -
SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation
por: Jurre A. Steens, et al.
Publicado: (2021) -
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.
por: John E Tavis, et al.
Publicado: (2013) -
Ira, fibromialgia y ansiedad: aproximación terapéutica desde un CSM.
por: Agustín Camino Vallhonrat, et al.
Publicado: (2009)